| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |
| M795474 | MACKLIN | 5-甲氧基色胺 | 10mM in DMSO | 185元/1ml; | 咨询 |
|
| M814464 | MACKLIN | 5-甲氧基色胺 | 97% | 29元/250mg; 32元/1g; 38元/5g; 112元/25g; 399元/100g; 1800元/500g; | 咨询 |
储存：2~8°C 状态：白色到棕褐色粉末,晶体和/或块状 |
| M0131 | TCI | 5-Methoxytryptamine | | 320元/100MG; 935元/1G; 1640元/5G; | 咨询 |
基本信息 | 分子式/分子量 | C11H14N2O = 190.25 | | 外观与形状(20℃) | 固体 | | Reaxys-RN | 145587 | | PubChem物质ID | 87572235 | | SDBS (AIST Spectral DB) | 4830 | | MDL编号 | MFCD00005662 |
技术规格 | Appearance | White to Light yellow to Light orange powder to crystal | | Purity(Nonaqueous Titration) | min. 98.0 % | | Melting point | 119.0 to 123.0 ℃ |
物性(参考值) 安全信息 | 图形或危害标志 |  | | 信号词 | 警告 | | 危险性说明 | H302 : 吞咽有害。
| | 防范说明 | P501 : 将内装物/容器送到批准的废物处理厂处理。
P270 : 使用本产品时不要进食、饮水或吸烟。
P264 : 作业后彻底清洗皮肤。
P301 + P312 + P330 : 如误吞咽：如感觉不适，呼叫急救中心/医生。漱口。
|
相关法规 |
| 161999 | J&K | 5-Methoxytryptamine | 98% | 798元/1G; 2214元/5G; 8859元/25G; | 咨询 |
基本信息 | 分子式 | C11H14N2O | | 分子量 | 190.24 | | 熔点 | 121 | | MDL编码 | MFCD00005662 | | Beilstein | 145587 | | EINECS 编号 | 210-153-7 |
安全信息 | 图形或危害标志 | | | 提示语 | Warning | | 危险说明 | H302 | | 防范说明 | P281 | | WGK | 3 | | RTECS | NL4059000 |
|
| 286583 | Sigma-Aldrich | 5-Methoxytryptamine | 97% | 434.39元/100 MG; 1200.69元/1 G; | 咨询 |
产品说明 一般描述 5-甲氧色胺(一种褪黑素的代谢物)在人角质细胞中应对紫外B(UVB)的保护性作用已得到研究。 应用 5-甲氧基色胺作为一种激动剂已被用于5-羟色胺1受体的药理作用研究中。
用于制备以下物质的反应物： - shishijimicin A的咔啉二糖结构域
- 褪黑激素类似物用于降低眼压
- 5-HT4受体配体
- 分选酶A和异柠檬酸裂解酶的抑制剂
- 用于治疗缺血/再灌注(I/R)损伤的治疗剂
- Aurora和表皮生长因子受体激酶抑制剂
- 用于治疗人乳头瘤病毒感染的药剂
- Manzamine类似物用于控制神经炎症和脑部感染
- 促炎细胞因子的抑制剂
- Tacrine-melatonin杂合物作为阿尔茨海默病的多功能药物
包装 1 g in glass bottle
100 mg in glass insert
无底玻璃瓶。内含物在插入的融合锥体内。 基本信息 | 经验(实验)分子式 | C11H14N2O | | 分子量 | 190.24 | | Beilstein | 145587 | | EC 号 | 210-153-7 | | MDL编号 | MFCD00005662 | | PubChem化学物质编号 | 24857245 | | NACRES | NA.22 |
产品性质 | 质量水平 | 200 | | 测定 | 97% | | mp | 121-123 ℃ (lit.) | | SMILES string | COc1ccc2[nH]cc(CCN)c2c1 | | InChI | 1S/C11H14N2O/c1-14-9-2-3-11-10(6-9)8(4-5-12)7-13-11/h2-3,6-7,13H,4-5,12H2,1H3 | | InChI key | JTEJPPKMYBDEMY-UHFFFAOYSA-N | | Gene Information | human ... HTR1A(3350), HTR2A(3356), HTR2C(3358)
rat ... Htr2a(29595), Htr2c(25187), Htr7(65032) |
安全信息 | 象形图 | | | 警示用语： | Warning | | 危险声明 | H302 | | 预防措施声明 | P264 - P270 - P301 + P312 + P330 - P501 | | 危险分类 | Acute Tox. 4 Oral | | 储存分类代码 | 13 - Non Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable | | 个人防护装备 | dust mask type N95 (US), Eyeshields, Gloves |
|
| 1380116 | USP | Melatonin Related Compound A | United States Pharmacopeia (USP) Reference Standard | 9633.46元/15 MG; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 非选择性血清素受体激动剂，不具有 5-HT3 受体亲和性。 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here.
Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C11H14N2O | | 分子量 | 190.24 | | Beilstein | 145587 | | MDL编号 | MFCD00005662 | | PubChem化学物质编号 | 329750347 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | USP | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | COc1ccc2[nH]cc(CCN)c2c1 | | InChI | 1S/C11H14N2O/c1-14-9-2-3-11-10(6-9)8(4-5-12)7-13-11/h2-3,6-7,13H,4-5,12H2,1H3 | | InChI key | JTEJPPKMYBDEMY-UHFFFAOYSA-N |
安全信息 | 象形图 | | | 警示用语： | Warning | | 危险声明 | H302 | | 预防措施声明 | P301 + P312 + P330 | | 危险分类 | Acute Tox. 4 Oral | | 储存分类代码 | 13 - Non Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| PHR2241 | Supelco | Melatonin Related Compound A | Pharmaceutical Secondary Standard; Certified Reference Material | 4695.46元/50 MG; | 咨询 |
产品说明 一般描述 Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards 应用 用于制备以下物质的反应物：
- shishijimicin A的咔啉二糖结构域
- 褪黑激素类似物用于降低眼压
- 5-HT4受体配体
- 分选酶A和异柠檬酸裂解酶的抑制剂
- 用于治疗缺血/再灌注(I/R)损伤的治疗剂
- Aurora和表皮生长因子受体激酶抑制剂
- 用于治疗人乳头瘤病毒感染的药剂
- Manzamine类似物用于控制神经炎症和脑部感染
- 促炎细胞因子的抑制剂
- Tacrine-melatonin杂合物作为阿尔茨海默病的多功能药物
分析说明 These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available. 其他说明 This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis. 附注 To see an example of a Certificate of Analysis for this material enter LRAC3413 in the Documents slot below. This is an example certificate only and may not be the lot that you receive. 基本信息 | 经验(实验)分子式 | C11H14N2O | | 分子量 | 190.24 | | Beilstein | 145587 | | MDL编号 | MFCD00005662 |
产品性质 | 等级 | certified reference material
pharmaceutical secondary standard | | 形式 | solid | | CofA | current certificate can be downloaded | | 包装 | pkg of 50 mg | | mp | 121-123 ℃ (lit.) | | 药典可追溯性 | traceable to USP 1380116 | | 储存温度 | -10 to -25℃ | | SMILES string | COc1ccc2[nH]cc(CCN)c2c1 | | InChI | 1S/C11H14N2O/c1-14-9-2-3-11-10(6-9)8(4-5-12)7-13-11/h2-3,6-7,13H,4-5,12H2,1H3 | | InChI key | JTEJPPKMYBDEMY-UHFFFAOYSA-N |
安全信息 | 象形图 | | | 警示用语： | Warning | | 危险声明 | H302 | | 预防措施声明 | P264 - P270 - P301 + P312 - P501 | | 危险分类 | Acute Tox. 4 Oral | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| BP1078 | | 5-Methoxytryptamine | British Pharmacopoeia (BP) Reference Standard | 2071.17元/25 MG; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 应用 用于制备以下物质的反应物：
- shishijimicin A的咔啉二糖结构域
- 褪黑激素类似物用于降低眼压
- 5-HT4受体配体
- 分选酶A和异柠檬酸裂解酶的抑制剂
- 用于治疗缺血/再灌注(I/R)损伤的治疗剂
- Aurora和表皮生长因子受体激酶抑制剂
- 用于治疗人乳头瘤病毒感染的药剂
- Manzamine类似物用于控制神经炎症和脑部感染
- 促炎细胞因子的抑制剂
- Tacrine-melatonin杂合物作为阿尔茨海默病的多功能药物
包装 Unit quantity: 25 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C11H14N2O | | 分子量 | 190.24 | | Beilstein | 145587 | | MDL编号 | MFCD00005662 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | BP | | mp | 121-123 ℃ (lit.) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | COc1ccc2[nH]cc(CCN)c2c1 | | InChI | 1S/C11H14N2O/c1-14-9-2-3-11-10(6-9)8(4-5-12)7-13-11/h2-3,6-7,13H,4-5,12H2,1H3 | | InChI key | JTEJPPKMYBDEMY-UHFFFAOYSA-N |
安全信息 | 象形图 | | | 警示用语： | Warning | | 危险声明 | H302 | | 预防措施声明 | P264 - P270 - P301 + P312 - P501 | | 危险分类 | Acute Tox. 4 Oral | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
m.cnreagent.com